title: Shingles vaccine: effective and costly or cost-effective?
authors.forename: Jeffrey P
authors.initials: JP
authors.lastname: Koplan
authors.forename: Rafael
authors.initials: R
authors.lastname: Harpaz
mesh_terms: D003362:Cost-Benefit Analysis; D006562:Herpes Zoster / Q000517:prevention & control*; D014645:Herpesvirus 3, Human / Q000276:immunology*; D022283:Herpesvirus Vaccines / Q000191:economics* / Q000627:therapeutic use; D006801:Humans; D051474:Neuralgia, Postherpetic / Q000517:prevention & control*
chemical_list: D022283:Herpesvirus Vaccines